FutureChem Co.,Ltd

KOSDAQ:A220100 Stock Report

Market Cap: ₩348.7b

FutureChemLtd Past Earnings Performance

Past criteria checks 0/6

FutureChemLtd has been growing earnings at an average annual rate of 3.5%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 11.7% per year.

Key information

3.5%

Earnings growth rate

22.9%

EPS growth rate

Life Sciences Industry Growth53.7%
Revenue growth rate11.7%
Return on equity-19.2%
Net Margin-67.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Does FutureChemLtd (KOSDAQ:220100) Have A Healthy Balance Sheet?

Dec 20
Does FutureChemLtd (KOSDAQ:220100) Have A Healthy Balance Sheet?

More Unpleasant Surprises Could Be In Store For FutureChem Co.,Ltd's (KOSDAQ:220100) Shares After Tumbling 27%

Nov 12
More Unpleasant Surprises Could Be In Store For FutureChem Co.,Ltd's (KOSDAQ:220100) Shares After Tumbling 27%

FutureChem Co.,Ltd's (KOSDAQ:220100) 29% Share Price Surge Not Quite Adding Up

Sep 04
FutureChem Co.,Ltd's (KOSDAQ:220100) 29% Share Price Surge Not Quite Adding Up

FutureChemLtd (KOSDAQ:220100) Is In A Good Position To Deliver On Growth Plans

Jun 13
FutureChemLtd (KOSDAQ:220100) Is In A Good Position To Deliver On Growth Plans

FutureChem Co.,Ltd (KOSDAQ:220100) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Apr 29
FutureChem Co.,Ltd (KOSDAQ:220100) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Revenues Not Telling The Story For FutureChem Co.,Ltd (KOSDAQ:220100)

Feb 26
Revenues Not Telling The Story For FutureChem Co.,Ltd (KOSDAQ:220100)

Is FutureChemLtd (KOSDAQ:220100) Using Debt In A Risky Way?

Feb 05
Is FutureChemLtd (KOSDAQ:220100) Using Debt In A Risky Way?

What Percentage Of FutureChem Co.,Ltd (KOSDAQ:220100) Shares Do Insiders Own?

Dec 14
What Percentage Of FutureChem Co.,Ltd (KOSDAQ:220100) Shares Do Insiders Own?

Revenue & Expenses Breakdown

How FutureChemLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A220100 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,734-10,5677,3833,240
30 Jun 2414,918-8,7267,1862,795
31 Mar 2414,391-7,6147,0082,485
31 Dec 2313,968-6,7096,8082,358
30 Sep 2313,589-10,2076,9365,277
30 Jun 2312,992-12,3126,5237,299
31 Mar 2313,020-12,1146,3756,998
31 Dec 2212,574-13,9596,1497,645
30 Sep 2211,705-10,3915,7024,910
30 Jun 2211,208-8,5615,6213,556
31 Mar 2211,090-9,0775,4914,901
31 Dec 2111,818-3,4205,3854,174
30 Sep 2112,913-16,2605,1313,807
30 Jun 2113,058-16,6134,9703,498
31 Mar 2112,740-16,6454,9771,881
31 Dec 2011,013-23,1014,8771,937
30 Sep 209,879-9,1474,7281,633
30 Jun 209,339-9,7604,6371,429
31 Mar 208,320-7,4984,3901,197
31 Dec 198,167-5,3684,356877
30 Sep 196,202-10,9254,645774
30 Jun 195,675-10,1254,593726
31 Mar 195,518-11,9634,738670
31 Dec 185,635-11,9694,598649
30 Sep 185,616-7,5203,886807
30 Jun 184,871-6,4333,865645
31 Mar 184,151-5,0423,401614
31 Dec 172,998-4,4913,129629
30 Sep 172,049-3,8872,819660
31 Dec 161,625-27,2861,966385
31 Dec 151,447-24,5291,695175
31 Dec 14703-3,905715152

Quality Earnings: A220100 is currently unprofitable.

Growing Profit Margin: A220100 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A220100 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.5% per year.

Accelerating Growth: Unable to compare A220100's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A220100 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (39.6%).

Return on Equity

High ROE: A220100 has a negative Return on Equity (-19.21%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 16:28
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

FutureChem Co.,Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wan KuNH Investment & Securities Co., Ltd.
Minyong EomShinhan Investment Corp.